| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.2M | +14.8% | +34.6% |
| R&D Expense | $3.7M | +0.2% | -22.8% |
| SG&A Expense | $6.3M | -9.2% | -27.1% |
| Operating Income | -$4.0M | +48.7% | +69.1% |
| Interest Expense | $568K | -3.1% | +14.5% |
| Income Tax | $0 | — | — |
| Net Income | -$4.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.2M | -34.6% | -70.2% |
| Accounts Receivable | $12.3M | +54.5% | +83.1% |
| Inventory | $3.9M | -15.2% | -1.5% |
| Current Assets | $22.5M | +5.1% | -3.3% |
| Total Assets | $81.0M | +1.1% | -20.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.6M | — | — |
| Investing Cash Flow | -$2.0M | — | — |
| Financing Cash Flow | $20.6M | — | — |
| +67.2% |
| EPS (Basic) | -$0.03 | +57.1% | +78.6% |
| $15.5M |
| +1.8% |
| -49.3% |
| Long-term Debt | $15.0M | +0.2% | -5.6% |
| Total Liabilities | $44.5M | -0.4% | -26.9% |
| Stockholders' Equity | $36.5M | +3.1% | -9.5% |